Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Elsevier’s ‘Hive Project’ to promote drug discovery

02-May-2016 - As a significant amount of drug discoveries occur outside of pharma companies, Elsevier has launched The Hive Project to promote innovation in the market – outside its walls.

WCT opens larger trial material depot in St Petersburg

26-Apr-2016 - Worldwide Clinical Trials (WCT) has opened a clinical trial material storage depot in St Petersburg, Russia citing increasing customer demand.

WHO says Semler Research manipulated data and warns repeat studies may needed

25-Apr-2016 - The WHO has accused Semler Research of data fraud and said Mylan, Micro Labs, Lupin and Strides and others may need to repeat bioanalytical trials conducted by the CRO.

Exco InTouch partners with Regulatory Strategies to meet data regulations

21-Apr-2016 - Exco InTouch has formed a strategic partnership with Regulatory Strategies, a data protection and compliance consultancy, in response to upcoming reforms.

BioClinica partnership to support 'continuum of pharmacovigilance services'

20-Apr-2016 - BioClinica and ArisGlobal have partnered to offer customers a comprehensive pharmacovigilance service as "one size fits all" model evolves.

Heptares, Kymab to develop novel antibody therapeutics in 'perfect marriage,' says CFO

19-Apr-2016 - Heptares Therapeutics and Kymab Limited have entered into a strategic collaboration to discover, develop, and commercialize novel antibody therapeutics.

Pfizer and IBM join forces to develop remote monitoring solutions

14-Apr-2016 - Using an experimental Internet of Things system that enables remote monitoring, the companies believe the multi-year project has the potential to change the way clinical trials are conducted.

Sekisui XenoTech expands cell- and tissue-based product catalog

13-Apr-2016 - Sekisui XenoTech announced that it now offers genotyped hepatocytes for polymorphic enzyme drug metabolism studies as part of its cell- and tissue-based product catalog.

Juno and WuXi AppTec announce new cell therapy company

13-Apr-2016 - The new company, JW Biotechnology, will draw on Juno’s immuno-oncology expertise and WuXi AppTec’s R&D and manufacturing platform.

Heat Biologics cuts patients in clinical trial, workforce

07-Apr-2016 - Heat Biologics has announced several "necessary" but "incredibly difficult" cost cutting measures, including a workforce reduction of approximately 22%.

inVentiv preps for $100m IPO

06-Apr-2016 - US CRO inVentiv Health has signaled its intention to go public by filing an S1 with the Securities and Exchange Commission (SEC) last night.

Evotec: Strong 2015 down to Sanofi strategic partnership

23-Mar-2016 - Evotec has attributed strong growth in 2015 to its deal with Sanofi and says it will continue to pursue such strategic partnerships.

Mexico office to bolster CRO Eurotrials' presence in Latin America

17-Mar-2016 - Eurotrials has opened an office in Mexico City in a bid the dominant CRO in the growing Mexican clinical research market.

BIA 10-2474: Expert calls for better pharmacology before protocols are approved

16-Mar-2016 - The drug industry needs to rethink what defines a ‘high-risk’ candidate say an expert calling for more detailed pharmacological studies in the wake of the BIA 10-2474 tragedy.

Exco Intouch and Oracle partner on EDC and ePRO system for trials

08-Mar-2016 - Exco InTouch has partnered with Oracle Health Sciences to develop an integrated EDC/ePRO system for clinical trials.

Study: Lack of enforcement means one third of US trials unreported

07-Mar-2016 - One-third of clinical-trials results in the US go unreported, according to new figures published in the British Medical Journal underlining how far the drugs industry remains from full transparency.

EFPIA welcomes EMA guidelines

EMA sets clear rules for drug firms seeking clinical data redactions

07-Mar-2016 - Drugmakers seeking to stop “commercially confidential information” being made public in trial reports will need to demonstrate the likely economic harm publishing it would cause says the EMA.

Synexus buys US trial site network for patient access; follows recent deals by Icon, PRA and PPD

07-Mar-2016 - Synexus has bought trial site network Research Across America (RAA) in a deal it claims will give its customers access to the US market and additional study participants.

Medpace to run Ph III trial of blood cancer ADC for Actinium

03-Mar-2016 - Medpace will run a Phase III trial of candidate blood cancer treatment Iomab-B under a new contract with developer Actinium Pharmaceuticals.

'No single magic bullet' as drug pricing debate wages

01-Mar-2016 - The drug pricing debate continues as Hillary Clinton releases a new campaign video attacking Valeant - but how did we get here? 

Identical ph III trials reveal different results

01-Mar-2016 - Genentech, a member of the Roche Group, has announced top-line results from two phase III studies, which had conflicting results.

Heat Biologics stops enrolment in trial arm testing HS-410 as a bladder cancer monotherapy

25-Feb-2016 - Heat Biologics will no longer enrol patients in the arm of a Phase II trial examining its cell therapy HS-410 (vesigenurtacel-L) as a monotherapy for bladder cancer.

Recipharm to buy Mitim for $75m in latest Italian antibiotics sector investment

24-Feb-2016 - Recipharm will pay SEK640m ($75m) for Italian antibiotic filling specialist Mitim in a deal expected to complete later today.

Unchained Labs continues breaking into biologics market

24-Feb-2016 - Unchained Labs has acquired Freeslate, a provider of high-throughput solutions for biologics formulation development and small molecule chemistry – marking the company’s 4th acquisition in 12 months.

300 years of genomics experience?! Parexel sets up ex GSK staff gene team

17-Feb-2016 - Parexel has set up a team of ex-GSK genomics experts in response to growing sponsor demand for “precision medicine” development knowhow.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...